Basilea Pharmaceutica AG (BPMUF)
Basilea Pharmaceutica Net Income (TTM) : 48.88M for Dec. 31, 2025
Net Income (TTM) Chart
Historical Data
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
Net Income (TTM) Benchmarks
| EvoNext Holdings SA | -0.765M |
| Kuros Biosciences Ltd. | -6.382M |
| Santhera Pharmaceuticals Holding AG | -75.68M |
| BeOne Medicines Ltd. | 287.73M |
| AC Immune SA | -84.61M |